Scientists Urge Stem Cell Reality Check
By Suzanne Bohan,
Alameda Times-Star
| 03. 20. 2008
HALF MOON BAY - In an elegant hotel overlooking the Pacific Ocean, more than 30 of the world's leading stem cell researchers gathered on Wednesday to strategize on the most effective means of developing novel stem cell medical treatments, while keeping public expectations in line with the actual state of scientific research.
The oft-cited potential of stem cells to one day possibly curing devastating ailments such as Parkinson's disease, spinal cord injuries and diabetes is also luring desperate patients to try so-called stem cell therapies abroad, six stem cell researchers at a noon news conference emphasized.
This "medical tourism" is almost certain to lead to disappointment and even danger, warned Dr. George Daley, president of the International Society for Stem Cell Research, which organized the daylong event at the Ritz-Carlton hotel.
"One has to be realistic. Cures take a very, very long time," Daley said. "One has to be very suspicious if a patient is asked to fly to a distant location and pay tens of thousands of dollars (for treatment). This is an invitation for exploitation."
These unproven treatments...
Related Articles
By Editors, Nature | 08.18.2026
Shinya Yamanaka doesn’t see himself as a celebrity. But people do recognize the stem-cell researcher when he’s out for a run, often while training for a marathon, on the streets of Kyoto, Japan.
Many of them call out words of...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
